RNA extraction | GenomeWeb

RNA extraction

NEW YORK (GenomeWeb News) – ZyGem today said that it has entered into an agreement with Quanta BioSciences to incorporate its enzymatic RNA-extraction technology into Quanta's quantitative PCR reagent kits.

ZyGem said today that it has signed an OEM agreement with Saudi Diagnostics, which will market ZyGem's DNA and RNA extraction kits for a variety of research applications.

GSK gains certain rights to Response Genetics' PCR analysis technology and diagnostic expertise to assess BRAF mutations in human tumor samples.

The company already offers many of these services to customers in North America and Europe through Gaithersburg, Md.-based subsidiary Gene Logic.

ZyGem's method, available in a commercial kit, can prepare samples in under 20 minutes, or up to ten times faster than existing RNA extraction products; while Genomic Health's method can access the entire transcriptome from formalin-fixed, paraffin-embedded tissues for downstream analyses.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.